Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortLow molecular weight heparin injection for clot prevention and cancer-related clots.Daily blood-thinning injection under the skin.
Body systemBlood & ClottingBlood & Clotting
Drug classHeparinsHeparins
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesPreventing clots after surgery, Clots in cancer, Unstable angina and NSTEMI, Keeping dialysis circuits openClot prevention in hospital and after surgery, Treating DVT and pulmonary embolism, Clots in pregnancy, Acute coronary syndrome
How it worksBlocks clot formation by boosting antithrombin.Mainly blocks clotting factor Xa.
Starts working3–4 hours—
Half-life3–5 hours4–7 hours
Typical adult dose5,000 units once a day for prevention; treatment doses are based on weight.Prevention: 40 mg once a day. Treatment: 1.5 mg/kg once a day or 1 mg/kg twice a day.
FormsSubcutaneous injectionPre-filled syringe
Common side effectsBruising, Injection site reactions, Raised liver enzymesBruising and small lumps at injection sites
Serious side effectsMajor bleeding, Heparin-induced low platelets, High potassium, Spinal haematomaBleeding, HIT (less than heparin), Spinal bleeding with epidural anaesthesia
Don't take ifActive bleeding; History of heparin-induced thrombocytopenia; Acute infective endocarditis—
AlcoholBest to limit. Alcohol raises bleeding risk.—
PregnancyGenerally considered safeHeparins do not cross the placenta and are used in pregnancy.Generally considered safeThe preferred anticoagulant in pregnancy.
BreastfeedingGenerally considered safeNot absorbed from the baby's gut.—
In use since—1987
Brand namesUnited States: FragminUnited Kingdom: FragminIndia: FragminUnited States: LovenoxUnited Kingdom: Clexane, InhixaIndia: Clexane, Lonopin
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeB01AB04B01AB05

Taken together

  • MajorDalteparin + Enoxaparin: Double anticoagulation — serious bleeding risk

    Two blood thinners together greatly increase the risk of major bleeding.

  • ModerateDalteparin + Enoxaparin: High potassium risk

    Both medicines can raise potassium. Kidney disease, diabetes and older age add to the risk.

Open in the interaction checker